Inventor · disambiguated record
Gaifa Lai
Also filed as: LAI GAIFA
8 granted patents·4 pending applications·134 citations·filing 2003–2012
88Inventor score
Top patents by PatentIndex Score
12 records- 0195US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0294US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0388US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 0486US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 0585US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 0685US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 0778US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 0869US7671212B2Isothiazole dioxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 2, 2010·4 cites·39 claims
- 0953US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 1049US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
- 1149US2009281075A1Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitorsPHARMACOPEIA INC·Filed 2008·Application pending·0 cites
- 1243US2008045489A13,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligandsCHAO JIANHUA·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gaifa Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →